Trending Market News

Unilever reported second-quarter underlying sales growth of 5.8%, exceeding analyst expectations of 4.3%. The consumer goods company's performance was driven by higher prices and strong demand for its home care and beauty brands as consumers favored trusted household names amid geopolitical uncertainty.

• Underlying sales growth of 5.8% significantly beat the consensus estimate of 4.3% for the quarter ended June 30
• Home care and beauty brands, including Dove soap and Axe deodorant, were key growth drivers
• Performance benefited from pricing power and consumer preference for established brands during uncertain times

Google faces a wave of private lawsuits seeking up to $10 billion in damages from European rivals following a record $1 billion EU fine under the Digital Markets Act for favoring its own services. The fine, combined with Google's loss of a long-running antitrust case, is emboldening smaller competitors across price comparison and other sectors to pursue compensation claims. This comes as Google has already paid €10.4 billion in EU fines over the past decade for anti-competitive practices.

• A German court awarded price comparison platform Idealo €465 million in November, Germany's largest antitrust damages award, setting precedent for similar cases across Europe
• Multiple lawsuits are underway in at least six countries, including claims from Sweden's PriceRunner (backed by Klarna) seeking $1.97 billion and UK-based Kelkoo seeking billions in damages
• Cases can take 5-8 years to resolve through appeals, with Google's shopping service case taking nearly two decades from initial alleged abuses to exhausted appeals, allowing the company to maintain market dominance during litigation

Mercedes-Benz reported a 22% increase in Q2 operating profit to €1.5 billion, slightly missing analyst expectations of €1.6 billion. The German automaker downgraded its full-year outlook, now forecasting declining sales and revenue due to weakness in China's car market, reversing its previous expectation of stagnation.

• Q2 EBIT reached €1.5 billion ($1.71 billion), supported by strong performance in financial services and vans units, plus a €131 million gain from selling its Athlon leasing subsidiary
• Mercedes now expects both car sales and group revenue to fall slightly below prior-year levels in 2026, downgrading from previous forecast of flat growth
• CEO Ola Kaellenius committed to additional cost-cutting measures in the second half of the year amid a 'demanding market environment' and ongoing product launches

Johnson & Johnson has offered $5.5 billion to settle approximately 76,000 U.S. lawsuits alleging its talcum powder caused ovarian cancer, though the company maintains the claims are 'meritless' and its products do not cause cancer. The settlement requires acceptance by legal firms representing 95% of claimants and could ultimately reach $7 billion, with J&J planning to pay $3 billion in 2027.

• J&J had won the vast majority of individual trials before offering the settlement, which the company frames as seeking closure rather than admitting liability
• The company faces similar legal action in the UK from thousands alleging baby powder caused ovarian cancer or mesothelioma between 1965 and 2023
• J&J previously discontinued its talcum-based baby powder and switched to a cornstarch product, having already settled most asbestos-related mesothelioma cases

Chinese automaker BYD launched its Racco electric mini-car in Japan on July 28, aiming to revive sales in a market where it has struggled since entering the passenger-car segment in 2023. The company is pricing the vehicle competitively at 1.95 million yen ($11,900) before taxes and subsidies to challenge Japan's best-selling electric mini-car, the Nissan Sakura.

• BYD's Racco is priced at 1.95 million yen ($11,900) before taxes and subsidies, undercutting Nissan's Sakura, currently Japan's best-selling electric mini-car
• The launch represents BYD's attempt to gain market traction in Japan after struggling since entering the country's passenger-car segment in 2023
• The competitive pricing strategy targets Japan's mini-car segment, a popular vehicle category in the country

Johnson & Johnson announced a $5.5 billion settlement to resolve tens of thousands of lawsuits alleging its baby powder and other talc products cause cancer. The settlement represents a major resolution to long-standing litigation that has plagued the company over safety concerns related to its talc-based products.

• The settlement will resolve tens of thousands of lawsuits related to talc product cancer allegations
• The agreement covers both baby powder and other talc-based products manufactured by J&J
• This represents one of the largest product liability settlements in recent corporate history

F5 raised its annual revenue growth forecast for the third time in 2024, now projecting 9-10% growth versus the prior 7-8% estimate, driven by strong demand for cybersecurity solutions. The network security company beat Q3 revenue expectations with $865 million versus the $832.6 million analyst estimate. The upgrade reflects increased business spending on security infrastructure amid rising AI-driven cyberattacks and ransomware threats.

• F5 increased its fiscal 2026 revenue growth forecast to 9-10%, up from the previous 7-8% projection, marking the third upward revision this year
• Third-quarter revenue of $865 million exceeded analyst expectations of $832.6 million, demonstrating robust demand for the company's network security and application delivery products
• Growing cybersecurity risks tied to AI adoption and ransomware are driving businesses worldwide to upgrade digital infrastructure and strengthen security operations

T-Mobile experienced a significant service outage on Monday, July 27, affecting thousands of users across multiple U.S. states. Downdetector.com recorded over 60,000 reports of service issues as of 4:39 p.m. ET, with users in Arizona, California, Georgia, and Utah among those impacted. T-Mobile did not immediately respond regarding the cause of the outage.

• More than 60,000 outage reports were logged on Downdetector.com as of 4:39 p.m. ET on Monday
• The outage affected users across multiple states including Arizona, California, Georgia, and Utah
• T-Mobile had not provided an explanation for the cause of the service disruption at the time of reporting

Banca Monte dei Paschi di Siena and Banco BPM are exploring a merger through their advisers, working on a deal structure that would combine cash and stock components. This development comes amid broader consolidation activity in Italy's banking sector, following Intesa Sanpaolo's recent bid for Banco BPM. Both banks declined to comment on the Bloomberg report.

• Advisers are developing a merger structure mixing cash and stock, though specific terms and valuations have not been disclosed
• The potential deal follows Intesa Sanpaolo's earlier acquisition offer for Banco BPM, indicating continued consolidation in Italian banking
• Monte dei Paschi, the world's oldest bank, has been undergoing restructuring including massive layoffs as part of planned corporate changes

CME Group launched cash-settled single-stock futures on 55 U.S. equities, including SpaceX and Micron Technology, trading nearly 24 hours a day on its Globex platform. The products allow investors to take leveraged long or short positions with lower capital requirements than traditional stock purchases, responding to market events outside regular trading hours. Morgan Stanley noted that over 35 retail partners are targeting immediate readiness, calling it the year's largest retail growth catalyst.

• Contracts trade from Sunday evening through Friday afternoon with only a one-hour daily maintenance break, enabling round-the-clock trading on 55 stocks plus micro-sized contracts on 22 names
• Standard contracts represent 100 shares and are traded on margin, offering simpler directional bets than options without time decay or implied volatility concerns
• The launch comes as CME faces competitive pressure from overseas perpetual futures exchanges, with the CFTC recently approving crypto 'perps' for Kalshi and Coinbase, potentially signaling broader regulatory shifts

NBCUniversal and YouTube have signed a multiyear deal to embed Peacock streaming content into YouTube Premium subscriptions starting early 2025. The partnership will give YouTube's 125 million Premium subscribers access to all Peacock content, including NFL and NBA sports, Universal films, and Bravo originals. This comes as traditional media companies seek new revenue streams amid declining pay-TV bundles and competition from tech platforms.

• Peacock has 48 million paying subscribers, while YouTube Premium has over 125 million global members, potentially expanding Peacock's reach significantly
• The deal was initiated by Comcast co-CEO Brian Roberts reaching out to YouTube CEO Neal Mohan nine months ago, following Comcast's announcement to split NBCUniversal from its parent company
• The partnership extends NBCUniversal's distribution agreement with YouTube TV and enhances advertising capabilities, allowing NBCUniversal to monetize ads for Peacock content on YouTube's platform

Sarepta Therapeutics appointed Michael Severino, former AbbVie president and Tessera Therapeutics CEO, as its new chief executive effective July 28, replacing Doug Ingram who is retiring after leading the company since 2017. The leadership change follows recent challenges including patient deaths linked to its gene therapy and discontinued programs.

• Severino brings extensive pharma experience from senior roles at AbbVie, Amgen, and Merck, and will join Sarepta's board while Ingram remains in an advisory role through 2026
• Under Ingram's leadership, Sarepta secured multiple Duchenne muscular dystrophy treatment approvals, but its gene therapy Elevidys was linked to two patient deaths
• The company recently discontinued several gene therapy programs for limb-girdle muscular dystrophy amid operational challenges

The FDA has approved Freenome's blood-based colorectal cancer screening test (SimpleScreen CRC) for adults aged 45 and older, marking the company's first commercial product. Partner Abbott will launch the test in the U.S. this fall, where it will compete with Guardant Health's offering. The approval triggers a $100 million milestone payment to Freenome and makes the test eligible for Medicare coverage.

• The test detected colorectal cancer with 81.1% sensitivity and high-risk precancerous growths with 30.7% sensitivity in a study of over 48,000 adults across 200+ sites
• Abbott will exclusively commercialize the test under a 2025 deal that includes a $100 million payment to Freenome tied to FDA approval
• Colorectal cancer is the third most commonly diagnosed cancer in the U.S., and the test meets Medicare coverage criteria while already being included in American Cancer Society screening guidelines

Amazon's Leo division has proposed launching a constellation of up to 5,105 satellites designed to provide direct-to-device voice and data connectivity. This initiative would enable smartphones and other devices to connect directly to satellites without requiring ground-based cellular infrastructure. The proposal positions Amazon to compete in the emerging satellite-to-phone communications market.

• The proposed constellation would include up to 5,105 satellites specifically designed for direct-to-device connectivity
• The service aims to provide both voice and data connectivity directly to consumer devices, bypassing traditional cellular networks
• This marks Amazon's expansion into direct-to-consumer satellite communications, competing with similar initiatives from SpaceX and other providers

Bernard Arnault, 77-year-old chairman of LVMH, publicly dismissed media reports suggesting a succession battle among his five children, calling such claims fiction. The lack of clear succession planning at the €230 billion luxury conglomerate has become a concern for investors, though Arnault has shown no signs of stepping down and recently raised the CEO age limit to 85.

• LVMH raised its chairman and CEO age limit to 85 in 2023, and Arnault suggested succession questions be revisited in seven to eight years when asked at the April annual meeting
• All five of Arnault's children hold senior roles within LVMH, managing various brands in the portfolio that includes Louis Vuitton, Dior, and Tiffany
• Arnault responded to Le Monde's reporting series on X, defending his family's unity and stating his children collaborate regularly, with 'Sunday calls' being normal family communication rather than plotting

OpenAI announced plans to more than triple its workforce at its Dublin European headquarters from over 100 to 350 employees over the next two years. The ChatGPT maker is leasing 8,000 square meters of office space in Dublin's Silicon Docks area, hiring 250 new positions in engineering and support operations.

• The Dublin office, which opened in 2023, will expand with 250 new hires over two years in engineering and support roles
• OpenAI is leasing 88,000 square feet of office space in Silicon Docks, where other U.S. tech giants like Google, Meta, and Microsoft have European headquarters
• The expansion comes as Ireland's government prioritizes AI investment, with foreign multinationals employing about 11% of Irish workers

Tesla won a UK Supreme Court ruling allowing it to pursue a lawsuit against InterDigital and patent licensing platform Avanci to determine fair licensing terms for 5G patents needed for its vehicles. The Supreme Court ruled that patent owners cannot avoid fair, reasonable and non-discriminatory (FRAND) licensing obligations simply by joining a patent pool. The case will now return to the High Court for further proceedings.

• Tesla originally sued InterDigital and Avanci in London's High Court in 2023 seeking FRAND terms for 5G patents ahead of launching 5G-enabled vehicles in Britain
• The Supreme Court overturned lower court rulings that had favored InterDigital and Avanci's request to dismiss Tesla's bid for FRAND licensing terms
• The ruling establishes that patent owners retain FRAND obligations even when participating in patent pools or licensing platforms, with Tesla receiving support from tech groups including CCIA and the Motion Picture Association

Online fast-fashion retailer Shein disclosed its financials for the first time in a Hong Kong IPO filing, revealing a $99 million loss in Q1 2026 due to slowing U.S. sales after the removal of a small-package import duty exemption and a one-time accounting charge. The company's valuation has dropped from $98.2 billion in 2022 to a target IPO range of $40-50 billion.

• Revenue grew from $32.1 billion in 2023 to $41.9 billion in 2025 (14.2% CAGR), but Q1 2026 growth slowed to just 1.1% year-over-year at $9 billion
• U.S. market share declined from 29.4% in 2023 to 22.5% in Q1 2026, with Q1 U.S. revenue falling 14% to $2 billion after duty exemption removal; Europe became the largest market at 35.4% of revenue
• Operating profit dropped 26% in Q1 2026 to $258 million as margins compressed to 2.9% from 3.9% year-earlier, reflecting rising marketing and fulfillment costs amid stagnant sales

French oil major TotalEnergies announced it will appeal a landmark French court ruling that orders the company to align its business with climate change obligations. The ruling holds Total responsible for planet-warming emissions released when customers use its fuel products, under France's corporate duty of vigilance law.

• The court decision marks a significant legal precedent by holding TotalEnergies liable for downstream emissions from customer use of its products, not just direct operational emissions
• The ruling is based on France's corporate duty of vigilance law, which requires companies to prevent environmental and human rights risks throughout their value chain
• TotalEnergies' appeal could set important legal precedent for how oil and gas companies are held accountable for their full carbon footprint globally

AstraZeneca's rare disease drug Ultomiris failed to meet its primary endpoint in a late-stage trial for a blood vessel complication following stem cell transplants, adding to a series of 2024 setbacks for the drugmaker. The failure raises concerns about AstraZeneca's pipeline as it pursues 20 new drug launches to reach $80 billion in annual revenue by 2030.

• Ultomiris missed statistical significance for event-free survival at 26 weeks in adult patients with stem cell transplant-associated thrombotic microangiopathy, though showed a positive trend
• A pediatric trial showed more promise with 87.2% overall survival at 26 weeks and 73.4% at 52 weeks, prompting AstraZeneca to advance regulatory filings for children
• The setback follows recent failures including a rejected breast cancer drug in May and comes as AstraZeneca targets $80 billion in annual revenue by 2030 through up to 20 new drug launches